What does CUSIP 795435AC0 represent in this 13F holders report?

CUSIP 795435AC0 is the security identifier for 795435AC0 - SALIX PHARMACEUTICALS INC - NOTE 2.750% 5/1 used to aggregate holder disclosures.

How many institutions held 795435AC0 - SALIX PHARMACEUTICALS INC - NOTE 2.750% 5/1 in Q2 2015?

No institutional holders were reported for 795435AC0 - SALIX PHARMACEUTICALS INC - NOTE 2.750% 5/1 in Q2 2015; review adjacent reporting periods for trend context.

SALIX PHARMACEUTICALS INC - NOTE 2.750% 5/1

CUSIP: 795435AC0

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Debt / NOTE 2.750% 5/1
Total 13F principal: $0
Principal change: -$300,648,000
Total reported market value: $0
Number of holders: 0
Value change: -$1,118,179,001
Number of sells: 19

Quarterly Holders Quick Answers

What is CUSIP 795435AC0?
CUSIP 795435AC0 identifies 795435AC0 - SALIX PHARMACEUTICALS INC - NOTE 2.750% 5/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q1 2015

Recent filing periods for CUSIP 795435AC0:

Q2 2015 Q1 2015 Q4 2014 Q3 2014 Q2 2014 Q1 2014 Q4 2013 Q3 2013

SALIX PHARMACEUTICALS INC - NOTE 2.750% 5/1

Q2 2015 13F Holders as of 30 Jun 2015

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of SALIX PHARMACEUTICALS INC - NOTE 2.750% 5/1 as of Q2 2015.